Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Dysregulation of the cohesin subunit RAD21 by Hepatitis C virus mediates host-virus interactions.

Perez S, Gevor M, Davidovich A, Kaspi A, Yamin K, Domovich T, Meirson T, Matityahu A, Brody Y, Stemmer SM, El-Osta A, Haviv I, Onn I, Gal-Tanamy M.

Nucleic Acids Res. 2019 Jan 30. doi: 10.1093/nar/gkz052. [Epub ahead of print]

PMID:
30698808
2.

Tumor cell density regulates matrix metalloproteinases for enhanced migration.

Jayatilaka H, Umanzor FG, Shah V, Meirson T, Russo G, Starich B, Tyle P, Lee JSH, Khatau S, Gil-Henn H, Wirtz D.

Oncotarget. 2018 Aug 24;9(66):32556-32569. doi: 10.18632/oncotarget.25863. eCollection 2018 Aug 24.

3.

Targeting invadopodia for blocking breast cancer metastasis.

Meirson T, Gil-Henn H.

Drug Resist Updat. 2018 Jul;39:1-17. doi: 10.1016/j.drup.2018.05.002. Epub 2018 May 17. Review.

PMID:
30075834
4.

Oral inflammation promotes oral squamous cell carcinoma invasion.

Goertzen C, Mahdi H, Laliberte C, Meirson T, Eymael D, Gil-Henn H, Magalhaes M.

Oncotarget. 2018 Jun 26;9(49):29047-29063. doi: 10.18632/oncotarget.25540. eCollection 2018 Jun 26.

5.

Intracerebroventricular Administration of L-arginine Improves Spatial Memory Acquisition in Triple Transgenic Mice Via Reduction of Oxidative Stress and Apoptosis.

Fonar G, Polis B, Meirson T, Maltsev A, Elliott E, Samson AO.

Transl Neurosci. 2018 May 31;9:43-53. doi: 10.1515/tnsci-2018-0009. eCollection 2018.

6.

Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.

Meirson T, Genna A, Lukic N, Makhnii T, Alter J, Sharma VP, Wang Y, Samson AO, Condeelis JS, Gil-Henn H.

Oncotarget. 2018 Apr 24;9(31):22158-22183. doi: 10.18632/oncotarget.25243. eCollection 2018 Apr 24.

7.

Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells.

Genna A, Lapetina S, Lukic N, Twafra S, Meirson T, Sharma VP, Condeelis JS, Gil-Henn H.

J Cell Biol. 2018 Jan 2;217(1):375-395. doi: 10.1083/jcb.201702184. Epub 2017 Nov 13.

8.

Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance.

Glantz-Gashai Y, Meirson T, Reuveni E, Samson AO.

Drug Des Devel Ther. 2017 Jun 19;11:1803-1813. doi: 10.2147/DDDT.S133127. eCollection 2017.

9.

An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.

Meirson T, Samson AO, Gil-Henn H.

Drug Des Devel Ther. 2017 May 18;11:1535-1557. doi: 10.2147/DDDT.S136150. eCollection 2017.

10.

Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndrome.

Aran A, Segel R, Kaneshige K, Gulsuner S, Renbaum P, Oliphant S, Meirson T, Weinberg-Shukron A, Hershkovitz Y, Zeligson S, Lee MK, Samson AO, Parsons SM, King MC, Levy-Lahad E, Walsh T.

Neurology. 2017 Mar 14;88(11):1021-1028. doi: 10.1212/WNL.0000000000003720. Epub 2017 Feb 10.

11.

Normal Modes Expose Active Sites in Enzymes.

Glantz-Gashai Y, Meirson T, Samson AO.

PLoS Comput Biol. 2016 Dec 21;12(12):e1005293. doi: 10.1371/journal.pcbi.1005293. eCollection 2016 Dec.

12.

Global antibiotic resistance is mostly periodic.

Dabour R, Meirson T, Samson AO.

J Glob Antimicrob Resist. 2016 Dec;7:132-134. doi: 10.1016/j.jgar.2016.09.003. Epub 2016 Oct 11. No abstract available.

PMID:
27788414
13.

Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia.

Meirson T, Orion E, Di Mario C, Webb C, Patel N, Channon KM, Ben Gal Y, Taggart DP.

J Thorac Cardiovasc Surg. 2015 Oct;150(4):871-8. doi: 10.1016/j.jtcvs.2015.04.061. Epub 2015 Jul 2.

14.

Numerical analysis of Venous External Scaffolding Technology for Saphenous Vein Grafts.

Meirson T, Orion E, Avrahami I.

J Biomech. 2015 Jul 16;48(10):2090-5. doi: 10.1016/j.jbiomech.2015.03.011. Epub 2015 Mar 19.

PMID:
25869720

Supplemental Content

Loading ...
Support Center